On this page
Crouzon syndrome
This condition causes the skull to develop an unusual shape due to early fusion of bone plates. It primarily affects the head and face, often becoming apparent in infancy and requiring specialist medical attention.
Available at Jeen Health
Clinical tests that include this
Overview
Crouzon syndrome is a rare genetic condition that primarily affects the skull and facial bones. It is characterised by craniosynostosis, which is the premature fusion of one or more fibrous joints (sutures) between the bones of the skull. This early fusion can restrict brain growth and lead to a distinctive head shape [PMID:3367123]. The condition typically becomes noticeable in infancy or early childhood. While the impact can vary between individuals, Crouzon syndrome often requires ongoing medical care and monitoring from a multidisciplinary team.
Symptoms & clinical features
The primary features of Crouzon syndrome relate to the head and face. Common signs include a distinctively shaped head, which can vary depending on which sutures fuse prematurely. Features often include widely spaced and bulging eyes (proptosis), a recessed midface, and an underdeveloped upper jaw. Visual problems may arise due to the shallow eye sockets, which can affect the eyelids' ability to fully close or potentially lead to optic nerve damage if left unmanaged [PMID:20301321]. Some individuals may experience hearing difficulties, often due to abnormalities in the middle ear [PMID:16583955]. Dental issues, such as crowding or malocclusion (misalignment of the teeth), are also frequently observed.
Video: Genetics 101
Affected organs
The main body systems affected in Crouzon syndrome are the skeletal structures of the head and face. This includes the bones of the skull, orbits (eye sockets), midface, and jaw. While the condition primarily impacts these areas, the resulting changes can indirectly affect other organs. For example, restricted skull growth can put pressure on the brain, and shallow eye sockets can impact vision. Hearing can also be affected due to structural changes in the ear bones.
Risks & severity
The severity of Crouzon syndrome can vary significantly among affected individuals. While some individuals may have milder features, others can experience more pronounced challenges. Early fusion of skull sutures can potentially lead to increased pressure within the skull (intracranial pressure), which, if severe, can affect brain development and function. Visual impairment is a potential risk, ranging from issues with eye closure to more severe complications like optic nerve compression [PMID:20301321]. Breathing difficulties, particularly during sleep, can also occur due to midfacial hypoplasia (underdevelopment of the midface). The exact prevalence of Crouzon syndrome is not well established, but some estimates suggest it affects approximately 1 in 25,000 live births.
Genetic causes
Crouzon syndrome is most commonly caused by pathogenic variants in the FGFR2 gene. This gene provides instructions for making a protein called fibroblast growth factor receptor 2. This receptor plays a crucial role in cell signalling pathways that are vital for cell growth, division, and the formation of bone during early development. Pathogenic changes in FGFR2 disrupt these normal signalling processes, leading to the premature fusion of skull bones [PMID:3367123]. In a smaller number of cases, pathogenic variants in the FGFR3 gene can also lead to a similar condition, sometimes referred to as Crouzon syndrome with acanthosis nigricans, which involves skin changes.
- FGFR2 fibroblast growth factor receptor 2The FGFR2 gene provides instructions for fibroblast growth factor receptor 2, a protein vital for cellular processes including growth, division, differentiation, and bone development.
Inheritance pattern
Crouzon syndrome generally follows an autosomal dominant inheritance pattern. This means that an individual only needs one copy of the altered FGFR2 gene to develop the condition. If a parent has Crouzon syndrome, there is a 50% chance in each pregnancy that their child will also inherit the condition. In many cases, Crouzon syndrome occurs as a new (de novo) pathogenic variant in an individual with no family history of the condition. In such instances, the chance of future children having Crouzon syndrome is generally low, similar to the general population risk, although specific genetic counselling should be sought.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of Crouzon syndrome typically begins with a clinical examination by a paediatrician or a craniofacial specialist based on the characteristic facial features and head shape. Imaging studies, such as X-rays, CT scans, or MRI scans, can be used to confirm the craniosynostosis and evaluate the associated bone abnormalities. Genetic testing, usually involving a blood sample, is often used to confirm the diagnosis by identifying pathogenic variants in the FGFR2 gene (R-code R115 Craniofacial disorders). This testing is generally requested by a clinical geneticist or another specialist following an initial clinical assessment. Referrals for genetic testing are typically made through NHS Genomic Medicine Service pathways.
Management & lifestyle
Management for Crouzon syndrome is multidisciplinary and focuses on addressing the specific clinical needs of each individual. It typically involves a team of specialists, including craniofacial surgeons, neurosurgeons, ophthalmologists, ENT specialists, and orthodontists. Surgical intervention is often necessary to correct craniosynostosis, relieve pressure on the brain, and improve facial appearance and function. This may involve multiple surgeries over time. Regular monitoring of vision and hearing is important, and interventions may be required to address any deterioration. Speech therapy, dental care, and psychological support are also often part of the comprehensive care plan. Management aims to optimise development and quality of life within the NHS framework.
UK care pathway
In the UK, individuals suspected of having Crouzon syndrome are typically referred to specialist craniofacial centres, often through the NHS Genomic Medicine Service. Clinical geneticists play a key role in confirming the diagnosis via genetic testing (e.g., R-code R115 Craniofacial disorders, R58 Exome sequencing). Genetic counsellors are available to provide support, explain the genetic basis of the condition, discuss inheritance patterns, and provide information about implications for the wider family.
Frequently asked questions
Is Crouzon syndrome always inherited from a parent?
No, not always. While it can be inherited from a parent, many cases of Crouzon syndrome result from a new genetic change (de novo variant) that occurs for the first time in the affected individual. In these cases, neither parent has the condition.
Will my child need surgery if they have Crouzon syndrome?
Many individuals with Crouzon syndrome do require surgical interventions to address craniosynostosis, relieve pressure on the brain, and improve facial structure. The specific type and timing of surgery will depend on your child's individual needs and symptoms, as determined by a specialist team.
Can Crouzon syndrome affect intelligence?
Crouzon syndrome itself does not typically affect intelligence. However, if severe craniosynostosis leads to increased pressure within the skull, this could potentially impact brain development. Regular monitoring is important to manage these risks.
What kind of doctors will be involved in my child's care?
A multidisciplinary team of specialists usually provides care for individuals with Crouzon syndrome. This often includes craniofacial surgeons, neurosurgeons, ophthalmologists, ENT specialists, geneticists, and orthodontists. Genetic counsellors also provide crucial support for families.
Where can I find support for my family in the UK?
In the UK, support for families affected by Crouzon syndrome can be accessed through specialist craniofacial centres and patient advocacy groups. Genetic counsellors can also provide information about support networks and resources.
References
- Zeppieri M, Karsonovich T, Patel BC. Crouzon Syndrome. 2025. PMID: 30085540
- Wang JC, Nagy L, Demke JC. Syndromic Craniosynostosis. Facial plastic surgery clinics of North America. 2016. PMID: 27712819
- Bhattacharjee K, Rehman O, Venkatraman V. Crouzon syndrome and the eye: An overview. Indian journal of ophthalmology. 2022. PMID: 35791116
- Al-Namnam NM, Hariri F, Thong MK. Crouzon syndrome: Genetic and intervention review. Journal of oral biology and craniofacial research. 2019. PMID: 30202723
- Huang S, Zhang D, Li B. Ocular manifestations and treatment progress of Crouzon syndrome. International ophthalmology. 2024. PMID: 39235629
- Alam MK, Alfawzan AA, Abutayyem H. Craniofacial characteristics in Crouzon's syndrome: A systematic review and meta-analysis. Science progress. 2023. PMID: 36803068
- Tiberio F, Polito L, Salvati M. Current Understanding of Crouzon Syndrome Pathophysiology and New Therapeutic Approaches. The Journal of craniofacial surgery. 2025. PMID: 40227035
- Jeftha A, Stephen L, Morkel JA. Crouzonodermoskeletal syndrome. The Journal of clinical pediatric dentistry. 2004. PMID: 14969379